Berger AK et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. American Heart Journal. 2007;153(6):1064-73.
Table I. Comparison of patients with CHF, stratified by renal function, page 1067
Table II. Characteristics associated with the inhospital administration of ACE-I or ARB, page 1069
Table III. Thirty-day adjusted mortality for CHF patients, stratified by inhospital prescription of ACE-I or ARB, page 1070
Ripley E. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease. American Heart Journal. 2009;157(6 Suppl):S7-S16.
Table I. Factors to consider when combining therapy for renal protection, page S14
- Alternative therapy cardiology critical care Dermatology Endocrinology & Metabolism gastroenterology GI & liver harm HEENT Hematology hepatology HIV Hospital medicine ID immunology infection Nephrology Neurology Oncology ophthalmology Orthopaedics patient satisfaction pulmonary medicine renal Reproductive health Rheumatology Surgery Syncope Toxicology Urology vascular